Researchers at University Medical Center Utrecht have uncovered a previously underappreciated mechanism that helps immune ...
The heart is able to adapt to changing conditions and demands by using a molecular mechanism known as alternative splicing.
Eclipse Bioinnovations, Inc. (Eclipsebio), the leader in sequencing-based analytics and AI-enabled design for RNA therapeutics, today announced the launch of eSENSE Break™, a sequencing-based ...
Researchers have uncovered a previously underappreciated mechanism that helps immune cells respond rapidly to infections.
Researchers discovered that recurring brain tumors can evolve in different ways, with some becoming more aggressive and ...
Systemic sclerosis is a rare connective tissue disorder characterised by autoimmune features with vascular manifestations, ...
Announcing a new article publication for Zoonoses journal. Varicella-zoster virus (VZV) is a clinically important human ...
Lilly, Ascidian Launch Up-to-$1.9B RNA Exon Editor Collaboration Targeting Inherited Kidney Diseases
Eli Lilly has expanded its genetic medicines pipeline and capabilities, agreeing to partner with Ascidian Therapeutics to develop RNA exon editors intended to treat inherited kidney diseases, through ...
The human heart must constantly adapt to changing demands—a task that requires tightly coordinated molecular shuffling in ...
A coalition of AI and science leaders is calling for tougher screening on orders of synthetic DNA, which can potentially be ...
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
A new study discovers a critical microglial cell transition that determines whether Alzheimer’s pathology causes dementia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results